These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28199736)

  • 21. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
    Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
    J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS.
    Shah A; Dodson WC; Kris-Etherton PM; Kunselman AR; Stetter CM; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Sluss PM; Coutifaris C; Dokras A; Legro RS
    J Clin Endocrinol Metab; 2021 Jan; 106(1):108-119. PubMed ID: 32968804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of the Modified Atherogenic Index of Plasma during Body Mass Reduction in Polish Obese/Overweight People.
    Zalejska-Fiolka J; Hubková B; Birková A; Veliká B; Puchalska B; Kasperczyk S; Błaszczyk U; Fiolka R; Bożek A; Maksym B; Mareková M; Birkner E
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30591697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
    Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
    Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
    Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
    Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
    Acta Obstet Gynecol Scand; 1985; 64(3):203-7. PubMed ID: 3160212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function.
    Aicher BO; Haser EK; Freeman LA; Carnie AV; Stonik JA; Wang X; Remaley AT; Kato GJ; Cannon RO
    Obesity (Silver Spring); 2012 Oct; 20(10):2057-62. PubMed ID: 22402736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.
    Maki KC; Beiseigel JM; Jonnalagadda SS; Gugger CK; Reeves MS; Farmer MV; Kaden VN; Rains TM
    J Am Diet Assoc; 2010 Feb; 110(2):205-14. PubMed ID: 20102847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS.
    Dokras A; Sarwer DB; Allison KC; Milman L; Kris-Etherton PM; Kunselman AR; Stetter CM; Williams NI; Gnatuk CL; Estes SJ; Fleming J; Coutifaris C; Legro RS
    J Clin Endocrinol Metab; 2016 Aug; 101(8):2966-74. PubMed ID: 27253669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.
    Dejager S; Pichard C; Giral P; Bruckert E; Federspield MC; Beucler I; Turpin G
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):455-62. PubMed ID: 11318780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
    Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
    Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
    Banaszewska B; Pawelczyk L; Spaczynski RZ; Dziura J; Duleba AJ
    J Clin Endocrinol Metab; 2007 Feb; 92(2):456-61. PubMed ID: 17105841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.
    Hernández-Mijares A; Bañuls C; Gómez-Balaguer M; Bergoglio M; Víctor VM; Rocha M
    Eur J Clin Invest; 2013 Jun; 43(6):549-56. PubMed ID: 23528141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.
    Villaseca P; Hormaza P; Cárdenas I; Oestreicher E; Arteaga E
    Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):155-65. PubMed ID: 15697105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.
    Glueck CJ; Aregawi D; Agloria M; Winiarska M; Sieve L; Wang P
    Metabolism; 2006 Dec; 55(12):1582-9. PubMed ID: 17142128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
    Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.